The FTC and congressional Democrats' joint efforts were touted at the White House in April, when Khan and Sanders joined President Biden to blast drug companies for what they said were attempts to take advantage of the patent system, such as tweaking the cap of an inhaler.
"They use the new patent on that cap to block generic drug companies from being able to enter the market," Biden said. "Playing these games with patients and pricing, Big Pharma is able to charge Americans significantly higher prices and pad their profits."…
No comments:
Post a Comment